Pancreatic Cancer Research

ResearcherUniversity of California San DiegoActive in the last 2 years

Dawn Jaquish

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-6673-1249; OpenAlex author ID A5110023184, A5110073409. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 8

  1. MICAL2 Promotes Pancreatic Cancer Growth and Metastasis. Co-author DOI 10.1158/0008-5472.can-24-0744↗
  2. A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-3210↗
  3. MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages. Co-author DOI 10.1038/s41388-019-0811-9↗
  4. Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy. Co-author DOI 10.1371/journal.pone.0189051↗
  5. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. Co-author DOI 10.1038/nature17988↗
  6. Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics. Co-author DOI 10.18632/oncotarget.10009↗
  7. The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome. Co-author DOI 10.1002/ijc.27447↗
  8. IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migration. Co-author DOI 10.1093/carcin/bgr086↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew M. Lowy · 8 shared papers, 2011–2025 · strength 0.57
  2. Hervé Tiriac · 2 shared papers, 2021–2025 · strength 0.30
  3. Alex Cazes · 2 shared papers, 2019–2021 · strength 0.20
  4. Divya Sood · 1 shared paper, 2025 · strength 0.17
  5. Bharti Garg · 1 shared paper, 2025 · strength 0.17
  6. Nirakar Rajbhandari · 1 shared paper, 2025 · strength 0.17
  7. Pnina Brodt · 1 shared paper, 2025 · strength 0.17
  8. Kevin Christian Montecillo Gulay · 1 shared paper, 2025 · strength 0.17
  9. Cosimo Commisso · 1 shared paper, 2025 · strength 0.17
  10. Steve Gallinger · 1 shared paper, 2025 · strength 0.17
  11. Michele L. Babicky · 3 shared papers, 2012–2019 · strength 0.15
  12. Jeffery M. Chakedis · 2 shared papers, 2016–2019 · strength 0.12
  13. Betzaira G. Childers · 1 shared paper, 2019 · strength 0.07
  14. Philippe Foubert · 1 shared paper, 2019 · strength 0.07
  15. Megan M. Harper · 1 shared paper, 2019 · strength 0.07
  16. Michael C. Schmid · 1 shared paper, 2019 · strength 0.07
  17. Judith A. Varner · 1 shared paper, 2019 · strength 0.07
  18. Kathleen E. DelGiorno · 1 shared paper, 2017 · strength 0.06
  19. Geoffrey Myles Wahl · 1 shared paper, 2017 · strength 0.06
  20. Maya Ridinger-Saison · 1 shared paper, 2017 · strength 0.06
  21. Ronald M. Evans · 1 shared paper, 2017 · strength 0.06
  22. David A Cheresh · 2 shared papers, 2011–2012 · strength 0.05
  23. Peter T. Yu · 2 shared papers, 2011–2012 · strength 0.05
  24. Nikki K. Lytle · 1 shared paper, 2016 · strength 0.04
  25. Raymond G. Fox · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.